[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.23.50.247. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
April 2, 2008

Sedation With Dexmedetomidine vs Lorazepam in Mechanically Ventilated Patients

JAMA. 2008;299(13):1540-1542. doi:10.1001/jama.299.13.1540-b

To The Editor: In the MENDS trial, Dr Pandharipande and colleagues1 concluded that dexmedetomidine infusion resulted in more days alive without delirium or coma and more time at the targeted level of sedation than with a lorazepam infusion. It remains unclear whether the study findings are due to the benefits of dexmedetomidine or are a result of the study design itself.

First Page Preview View Large
First page PDF preview
First page PDF preview
×